Logo image of EXPL.PA

EXPLOSIFS PROD. CHI (EXPL.PA) Stock Fundamental Analysis

Europe - EPA:EXPL - FR0014003AQ4 - Common Stock

204 EUR
-1 (-0.49%)
Last: 11/7/2025, 7:00:00 PM
Fundamental Rating

6

EXPL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. While EXPL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EXPL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year EXPL was profitable.
In the past year EXPL had a positive cash flow from operations.
Of the past 5 years EXPL 4 years were profitable.
In the past 5 years EXPL always reported a positive cash flow from operatings.
EXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFEXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

EXPL has a better Return On Assets (4.98%) than 72.73% of its industry peers.
EXPL's Return On Equity of 14.04% is amongst the best of the industry. EXPL outperforms 83.33% of its industry peers.
With a decent Return On Invested Capital value of 6.36%, EXPL is doing good in the industry, outperforming 63.64% of the companies in the same industry.
EXPL had an Average Return On Invested Capital over the past 3 years of 6.01%. This is in line with the industry average of 7.12%.
The 3 year average ROIC (6.01%) for EXPL is below the current ROIC(6.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROIC 6.36%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
EXPL.PA Yearly ROA, ROE, ROICEXPL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Profit Margin of EXPL (4.77%) is better than 60.61% of its industry peers.
EXPL's Profit Margin has improved in the last couple of years.
EXPL has a Operating Margin (4.22%) which is in line with its industry peers.
EXPL's Operating Margin has improved in the last couple of years.
EXPL's Gross Margin of 60.41% is amongst the best of the industry. EXPL outperforms 89.39% of its industry peers.
EXPL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
EXPL.PA Yearly Profit, Operating, Gross MarginsEXPL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXPL is destroying value.
EXPL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EXPL has been increased compared to 5 years ago.
Compared to 1 year ago, EXPL has an improved debt to assets ratio.
EXPL.PA Yearly Shares OutstandingEXPL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
EXPL.PA Yearly Total Debt VS Total AssetsEXPL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

EXPL has an Altman-Z score of 2.71. This is not the best score and indicates that EXPL is in the grey zone with still only limited risk for bankruptcy at the moment.
EXPL has a better Altman-Z score (2.71) than 63.64% of its industry peers.
EXPL has a debt to FCF ratio of 2.38. This is a good value and a sign of high solvency as EXPL would need 2.38 years to pay back of all of its debts.
EXPL has a Debt to FCF ratio of 2.38. This is amongst the best in the industry. EXPL outperforms 92.42% of its industry peers.
EXPL has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
EXPL's Debt to Equity ratio of 0.40 is in line compared to the rest of the industry. EXPL outperforms 56.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Altman-Z 2.71
ROIC/WACC0.84
WACC7.61%
EXPL.PA Yearly LT Debt VS Equity VS FCFEXPL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.26 indicates that EXPL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.26, EXPL is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
EXPL has a Quick Ratio of 1.26. This is a bad value and indicates that EXPL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.94, EXPL is not doing good in the industry: 60.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
EXPL.PA Yearly Current Assets VS Current LiabilitesEXPL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.37% over the past year.
The Earnings Per Share has been growing by 51.47% on average over the past years. This is a very strong growth
Looking at the last year, EXPL shows a small growth in Revenue. The Revenue has grown by 5.49% in the last year.
The Revenue has been growing slightly by 7.27% on average over the past years.
EPS 1Y (TTM)14.37%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%9.14%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%7.52%

3.2 Future

EXPL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.53% yearly.
The Revenue is expected to grow by 5.20% on average over the next years.
EPS Next Y7.4%
EPS Next 2Y19.69%
EPS Next 3Y16.53%
EPS Next 5YN/A
Revenue Next Year6.67%
Revenue Next 2Y6.51%
Revenue Next 3Y5.2%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXPL.PA Yearly Revenue VS EstimatesEXPL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
EXPL.PA Yearly EPS VS EstimatesEXPL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.62 indicates a rather expensive valuation of EXPL.
Compared to the rest of the industry, the Price/Earnings ratio of EXPL indicates a somewhat cheap valuation: EXPL is cheaper than 68.18% of the companies listed in the same industry.
EXPL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.83.
EXPL is valuated reasonably with a Price/Forward Earnings ratio of 11.61.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXPL indicates a rather cheap valuation: EXPL is cheaper than 84.85% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 32.68. EXPL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.62
Fwd PE 11.61
EXPL.PA Price Earnings VS Forward Price EarningsEXPL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

EXPL's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, EXPL is valued cheaply inside the industry as 89.39% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.36
EV/EBITDA 11.13
EXPL.PA Per share dataEXPL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of EXPL may justify a higher PE ratio.
A more expensive valuation may be justified as EXPL's earnings are expected to grow with 16.53% in the coming years.
PEG (NY)2.38
PEG (5Y)N/A
EPS Next 2Y19.69%
EPS Next 3Y16.53%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.73%, EXPL is not a good candidate for dividend investing.
EXPL's Dividend Yield is slightly below the industry average, which is at 3.25.
Compared to an average S&P500 Dividend Yield of 2.37, EXPL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.73%

5.2 History

The dividend of EXPL decreases each year by -6.39%.
Dividend Growth(5Y)-6.39%
Div Incr Years1
Div Non Decr Years1
EXPL.PA Yearly Dividends per shareEXPL.PA Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.5 1

5.3 Sustainability

EXPL pays out 9.03% of its income as dividend. This is a sustainable payout ratio.
DP9.03%
EPS Next 2Y19.69%
EPS Next 3Y16.53%
EXPL.PA Yearly Income VS Free CF VS DividendEXPL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M
EXPL.PA Dividend Payout.EXPL.PA Dividend Payout, showing the Payout Ratio.EXPL.PA Dividend Payout.PayoutRetained Earnings

EXPLOSIFS PROD. CHI

EPA:EXPL (11/7/2025, 7:00:00 PM)

204

-1 (-0.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)09-29 2025-09-29
Earnings (Next)N/A N/A
Inst Owners3.75%
Inst Owner ChangeN/A
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap461.04M
Revenue(TTM)508.38M
Net Income(TTM)23.37M
Analysts82.86
Price Target221.34 (8.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.73%
Yearly Dividend1
Dividend Growth(5Y)-6.39%
DP9.03%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.66%
EPS NY rev (3m)-10.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.47%
Revenue NY rev (3m)3.35%
Valuation
Industry RankSector Rank
PE 17.62
Fwd PE 11.61
P/S 0.94
P/FCF 11.36
P/OCF 6.87
P/B 2.77
P/tB 3.08
EV/EBITDA 11.13
EPS(TTM)11.58
EY5.68%
EPS(NY)17.56
Fwd EY8.61%
FCF(TTM)17.96
FCFY8.81%
OCF(TTM)29.69
OCFY14.55%
SpS216.88
BVpS73.67
TBVpS66.32
PEG (NY)2.38
PEG (5Y)N/A
Graham Number138.54
Profitability
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROCE 7.48%
ROIC 6.36%
ROICexc 6.41%
ROICexgc 6.82%
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
FCFM 8.28%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
ROICexc(3y)6.49%
ROICexc(5y)5.43%
ROICexgc(3y)6.91%
ROICexgc(5y)5.79%
ROCE(3y)7.04%
ROCE(5y)5.85%
ROICexgc growth 3Y2.1%
ROICexgc growth 5Y14.44%
ROICexc growth 3Y2.48%
ROICexc growth 5Y15.88%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Debt/EBITDA 1.33
Cap/Depr 91.37%
Cap/Sales 5.41%
Interest Coverage 3.37
Cash Conversion 135.01%
Profit Quality 173.71%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.71
F-Score6
WACC7.61%
ROIC/WACC0.84
Cap/Depr(3y)105.91%
Cap/Depr(5y)86.48%
Cap/Sales(3y)5.43%
Cap/Sales(5y)5.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.37%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%9.14%
EPS Next Y7.4%
EPS Next 2Y19.69%
EPS Next 3Y16.53%
EPS Next 5YN/A
Revenue 1Y (TTM)5.49%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%7.52%
Revenue Next Year6.67%
Revenue Next 2Y6.51%
Revenue Next 3Y5.2%
Revenue Next 5YN/A
EBIT growth 1Y22.43%
EBIT growth 3Y16.9%
EBIT growth 5Y23.09%
EBIT Next Year88.7%
EBIT Next 3Y32.83%
EBIT Next 5YN/A
FCF growth 1Y284.59%
FCF growth 3Y49.53%
FCF growth 5Y77.86%
OCF growth 1Y102.52%
OCF growth 3Y33.74%
OCF growth 5Y25.45%

EXPLOSIFS PROD. CHI / EXPL.PA FAQ

What is the ChartMill fundamental rating of EXPLOSIFS PROD. CHI (EXPL.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXPL.PA.


Can you provide the valuation status for EXPLOSIFS PROD. CHI?

ChartMill assigns a valuation rating of 7 / 10 to EXPLOSIFS PROD. CHI (EXPL.PA). This can be considered as Undervalued.


Can you provide the profitability details for EXPLOSIFS PROD. CHI?

EXPLOSIFS PROD. CHI (EXPL.PA) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for EXPL stock?

The Price/Earnings (PE) ratio for EXPLOSIFS PROD. CHI (EXPL.PA) is 17.62 and the Price/Book (PB) ratio is 2.77.


Can you provide the financial health for EXPL stock?

The financial health rating of EXPLOSIFS PROD. CHI (EXPL.PA) is 5 / 10.